Effects of Glycogen Synthase Kinase3β Silencing on Cell Growth and Epithelial-Mesenchymal Transition in Pancreatic Cancer PANC1 Cells
宋博,马洪运,李森,邵卓,宋彬,郝俊,程鹏,金钢
DOI: https://doi.org/10.3760/cma.j.issn.1674-1935.2016.02.002
2016-01-01
Abstract:Objective To study the effect of inhibiting glycogen synthase kinase3β (GSK3β) on cell proliferation and epithelial mesenchymal transition (EMT) in pancreatic cancer PANC1 cells.Methods The siRNA trageting GSK3β (siRNA-GSK3β) and negative control siRNA (siRNA-NC) were synthesized to transfect pancreatic cancer PANC1 cells.MTT assay was used to detect cell proliferation.mRNA expression of Wnt,β-catenin,C-myc,CyclinD1 in Wnt/β-catenin signaling,Shh and Smo in Hedgehog pathway,PI3K,Akt,mTOR,4E-BP1,p70S6K in PI3K/Akt/mTOR signal pathway and Slug,Snail,Twist,E-cadherin,N-cadherin,Vimentin involved in EMT were detected by RT-PCR.Results GSK3β mRNA expression was 1 in cells transfected with siRNA-NC,which was 0.25 ± 0.08,0.62 ± 0.09,0.70 ± 0.11 in cells with 3different siRNA-GSK3βs,respectively.GSK3β mRNA was significantly decreased by transfection of siRNA-GSK3β(P<0.0001).The cell proliferation of siRNA-GSK3β group was significantly lower than that of siRNA-NC group(P <0.05).Wnt,β-catenin,C-myc,CyclinD1,PI3K,Akt,mTOR,4E-BP1,p70S6K,Slug,Snail,N-cadherin,Vimentin mRNA in cells transfected with siRNA-GSK3β was 0.28 ± 0.04,0.47 ±0.05,0.37±0.05,0.62±0.08,0.22±0.03,0.47±0.06,0.65±0.08,0.39±0.04,0.56±0.07,0.33 ± 0.05,0.46 ± 0.07,0.55 ± 0.06,0.38 ± 0.04,which were greatly lower than those in cells transfected with siRNA-NC,and the difference was statistically significant (all P <0.05).Shh and Smo mRNA was 1.10 ±0.13 and 1.05 ±0.11,which was comparable with those in cells with siRNA-NC.Twist mRNA was 0.62 ± 0.08,which was lower than that in cells with siRNA-NC,while E-cadherin mRNA was 2.12 ±0.25,which was higher than that in cells with siRNA-NC,but the differences were not statistically significant.Conclusions GSK3β silencing in PANC1 cells can suppress cell proliferation and EMT of pancreatic cancer cells by regulating Wnt/β-catenin and PI3K/Akt pathway.